Study for the Medical Council of Canada Qualifying Examination (MCCQE) I. Engage with flashcards and multiple-choice questions with detailed feedback. Prepare confidently!

Multiple Choice

A COPD patient presents with increased dyspnea; what features indicate need for systemic steroids and antibiotics?

In acute COPD exacerbations, clinicians base treatment on a set of hallmark symptoms: increased dyspnea, increased sputum volume, and purulent sputum. Antibiotics are recommended when two of these three features are present, with purulence specifically pointing to a bacterial component driving the flare. Systemic corticosteroids are commonly used in acute exacerbations to speed up recovery, improve lung function, and reduce the likelihood of treatment failure or hospitalization. The scenario describes a patient with worsening dyspnea along with both increased sputum volume and purulence. This satisfies at least two of the three cardinal symptoms, and the presence of purulence signals a bacterial infection, making systemic antibiotics appropriate. The combination of systemic steroids is also supported in an acute exacerbation to hasten improvement. In contrast, improvement in dyspnea and sputum would not indicate the need for antibiotics or steroids, no change in symptoms suggests stability rather than an exacerbation, and fever without dyspnea lacks the key COPD-specific changes that trigger these therapies.

In acute COPD exacerbations, clinicians base treatment on a set of hallmark symptoms: increased dyspnea, increased sputum volume, and purulent sputum. Antibiotics are recommended when two of these three features are present, with purulence specifically pointing to a bacterial component driving the flare. Systemic corticosteroids are commonly used in acute exacerbations to speed up recovery, improve lung function, and reduce the likelihood of treatment failure or hospitalization.

The scenario describes a patient with worsening dyspnea along with both increased sputum volume and purulence. This satisfies at least two of the three cardinal symptoms, and the presence of purulence signals a bacterial infection, making systemic antibiotics appropriate. The combination of systemic steroids is also supported in an acute exacerbation to hasten improvement.

In contrast, improvement in dyspnea and sputum would not indicate the need for antibiotics or steroids, no change in symptoms suggests stability rather than an exacerbation, and fever without dyspnea lacks the key COPD-specific changes that trigger these therapies.